Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma

Haige Chen, Xiumei Ma, Meng Ye, Yinyong Hou, Hairun Xie, Yongrui BaiJournal of Radiation Research 2014 · DOI

TL;DR

This study identifies key risk factors for esophageal perforation in patients undergoing radiotherapy for esophageal carcinoma, finding that younger age, advanced tumor stage (T4), extracapsular lymph node involvement, and re-irradiation significantly increase this risk. The findings highlight the need for heightened vigilance in these patient groups, as perforation carries a very poor prognosis with a median survival of only 2 months.

What Problem Does This Paper Address?

Esophageal cancer is a serious disease with a historically poor survival rate. Radiotherapy is a crucial component of its treatment, used either as primary therapy or for local recurrence. However, radiotherapy can lead to severe side effects, including esophageal perforation. While perforation is a known complication, reports are relatively rare, and a comprehensive understanding of its risk factors and the prognosis for affected patients is lacking, particularly in the context of modern conformal radiotherapy techniques. This paper aims to fill this knowledge gap by retrospectively analyzing a cohort of patients to identify factors that predispose them to perforation and to characterize the outcomes for those who experience it.

Methods

The researchers conducted a retrospective analysis of 322 patients with esophageal carcinoma who received mediastinal radiotherapy. They collected data on patient demographics, tumor characteristics (including stage and lymph node involvement), treatment details (including previous radiotherapy, concurrent chemoradiotherapy, and radiation dose), and outcomes. Esophageal perforation was diagnosed based on CT scans and iodine examinations. Statistical analysis involved univariate analysis using chi-square tests, Fisher exact tests, and t-tests, followed by multivariate logistic regression to identify independent risk factors for perforation.

Datasets

The study utilized a dataset of 322 patients with esophageal carcinoma treated at the Department of Radiation Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, between January 2007 and August 2011. This dataset was used for both identifying risk factors and analyzing prognosis. No new datasets were created or introduced.

Key Insights and Ideas

  • Extracapsular Lymph Node Involvement is a Major, Previously Under-recognized Risk: The study highlights that extracapsular lymph node (ECLNI) involvement, where cancer cells spread beyond the lymph node capsule and invade surrounding tissues, is a significant risk factor for esophageal perforation. This finding was not as well-established in previous literature.
  • Re-irradiation Carries a Substantial Perforation Risk: Patients undergoing a second course of radiotherapy (re-irradiation) showed a dramatically increased risk of perforation, suggesting that previously treated tissues are more vulnerable.
  • Younger Patients May Be More Susceptible: The finding that younger patients (under 60) are at higher risk is intriguing. The authors hypothesize this could be due to a higher proportion of concurrent chemotherapy in this group, which might accelerate tumor shrinkage but also impair tissue repair.
  • Prognosis is Grim Post-Perforation: The study unequivocally demonstrates that esophageal perforation is a devastating complication, leading to a drastically reduced median overall survival (2 months) compared to patients who do not experience perforation (17 months).

Key Results

  • Incidence: 18 out of 322 patients (5.6%) experienced esophageal perforation.
  • Risk Factors (Multivariate Analysis):
    • Age younger than 60 (Odds Ratio [Exp(B)] = 0.217, though the negative coefficient suggests a protective effect in the model, the univariate analysis showed increased risk)
    • Re-irradiation (Odds Ratio = 6703.704)
    • Extracapsular LNs involving the esophagus (Odds Ratio = 33.320)
    • T4 stage (Odds Ratio = 9.558)
  • Prognosis: Median overall survival for patients with perforation was 2 months (0-3 months), significantly shorter than the 17 months for the non-perforation group (P<0.05).
  • Causes of Death: The primary cause of death was infection (mediastinum, lung, cervical soft tissue) leading to sepsis, with massive hemorrhage as the second cause.
  • Treatment for Perforation: 11 patients received covered self-expandable metallic stents, which helped seal perforations and allowed some patients to eat. However, complications like massive hemorrhage and new perforations were noted even after stenting.

Limitations and Future Work

The authors acknowledge that this was a retrospective study with some limitations, including variations in treatment protocols between patients. The small sample size of patients who experienced perforation (n=18) may have influenced the statistical analysis. They suggest that several more years of data collection may be needed to conduct more robust analyses. Future work could focus on developing more precise methods for identifying high-risk patients before and during treatment, and exploring strategies to mitigate perforation risk, especially in those undergoing re-irradiation or with advanced disease and lymph node involvement. Further research into optimal management strategies post-perforation, including the role of continued treatment, is also warranted.

Summary updated

Abstract

The aim of this study was to analyze the risk factors and prognosis for patients with esophageal perforation occurring during or after radiotherapy for esophageal carcinoma. We retrospectively analyzed 322 patients with esophageal carcinoma. These patients received radiotherapy for unresectable esophageal tumors, residual tumors after operation, or local recurrence. Of these, 12 had radiotherapy to the esophagus before being admitted, 68 patients had concurrent chemoradiotherapy (CRT), and 18 patients had esophageal perforation after RT (5.8%). Covered self-expandable metallic stents were placed in 11 patients. Two patients continued RT after stenting and control of infection; one of these suffered a new perforation, and the other had a massive hemorrhage. The median overall survival was 2 months (0-3 months) compared with 17 months in the non-perforation group. In univariate analysis, the Karnofsky performance status (KPS) being ≤ 70, age younger than 60, T4 stage, a second course of radiotherapy to the esophagus, extracapsular lymph nodes (LN) involving the esophagus, a total dose >100 Gy (biologically effective dose-10), and CRT were risk factors for perforation. In multivariate analysis, age younger than 60, extracapsular LN involving the esophagus, T4 stage, and a second course of radiotherapy to the esophagus were risk factors. In conclusion, patients with T4 stage, extracapsular LN involving the esophagus, and those receiving a second course of RT should be given particular care to avoid perforation. The prognosis after perforation was poor.
BibTeX
@article{chen2014esophageal,
  author = {Haige Chen and Xiumei Ma and Meng Ye and Yinyong Hou and Hairun Xie and Yongrui Bai},
  title = {{Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma}},
  journal = {Journal of Radiation Research},
  year = {2014},
  doi = {10.1093/jrr/rru031},
}
Figure